Table:
begin	end	state
1	6	cytoplasmic
7	25	transmembrane
26	30	non-cytoplasmic
31	48	transmembrane
49	54	cytoplasmic
55	72	transmembrane
73	87	non-cytoplasmic
88	108	transmembrane
109	115	cytoplasmic
116	140	transmembrane
141	146	non-cytoplasmic
147	166	transmembrane
167	177	cytoplasmic
178	203	transmembrane
204	218	non-cytoplasmic
219	241	transmembrane
242	272	cytoplasmic
273	291	transmembrane
292	296	non-cytoplasmic
297	315	transmembrane
316	326	cytoplasmic
327	349	transmembrane
350	361	non-cytoplasmic
362	381	transmembrane
382	387	cytoplasmic
388	415	transmembrane
416	444	non-cytoplasmic
445	468	transmembrane
469	477	cytoplasmic

Input:
>BWI76_RS04375
MQKNKLWKLLVIIAIPLLISLFPAPEGLSKLAWVLSGIYLAAIVGLVIKPFAEPVVLLIA
VAASMVVVGNLGDGSIKAASVLSGYSSGTTWLVFSAFTLSAAFVITGLGKRIAYILIGKI
GSTTLGLGYVTAFLDLILAPATPSNTARAGGIVLPIINSVAVALGSEPERSAKRVGHYLM
LNVYMVTKTTSYMFFTAMAGNILALKMIEDICHIKLSWGGWALAAGLPGIIMLLLTPLIT
YKLYPPELKKVDNKKIAKAGMEALGPMTLREKMLSCLFVLALGGWVFSQSLGVNESTVAI
GVMALMLVLRIVTWDDVIKNKGGWNTLIWYGGIIGLSSLLSKVGFFLWLADLLKNNISFN
GHGNVAFIVIVALSILVRYFFASGSAYIVAMVPVFAMLANVSGAPVMLTALALLFSNSYG
GMVTHYGGAAGPVIFGVGYNDIKSWWIIGGILALLTFLLQITLGVWWWEILIAWKVI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server